ASSESSMENT OF THE EFFECTIVENESS OF CORRECTING INTESTINAL MICROBIOCENOSIS IN THE COMPREHENSIVE MANAGEMENT OF RECURRENT BACTERIAL VULVOVAGINITIS IN ADOLESCENT GIRLS
Keywords:
Adolescent girls, vulvovaginitis, bacterial vulvovaginitis, recurrence, intestinal microbiocenosis, probiotics, Lactobacillus, microbiota, comprehensive treatment, prevention.Abstract
To evaluate the clinical, microbiological, and preventive efficacy of correcting intestinal microbiocenosis in addition to standard antibacterial therapy in the comprehensive treatment of recurrent bacterial vulvovaginitis in adolescent girls.
The statistical model was developed based on data from 120 adolescent girls aged 12–17 years. Participants were divided into a main group and a control group of 60 patients each. In the main group, a probiotic approach aimed at correcting intestinal microbiocenosis was administered alongside standard etiotropic treatment, whereas the control group received the standard treatment regimen. Clinical symptoms, vaginal pH, as well as microscopic and microbiological parameters were assessed before and after treatment, as well as during the 3- and 6-month follow-up periods.
References
1.Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis. 2019;46:304–311.
2.Bilardi JE, Walker S, Temple-Smith M, et al. The burden of bacterial vaginosis: women's experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS One. 2013;8:e74378.
3.van de Wijgert JHHM, Jespers V. The global health impact of vaginal dysbiosis. Res Microbiol. 2017;168:859–864.
4.Jung HS, Ehlers MM, Lombaard H, Redelinghuys MJ, Kock MM. Etiology of bacterial vaginosis and polymicrobial biofilm formation. Crit Rev Microbiol. 2017;43:651–667.
5.Coudray MS, Madhivanan P. Bacterial vaginosis-A brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol. 2020;245:143–148.
6.Swidsinski A, Loening-Baucke V, Mendling W, et al. Infection through structured polymicrobial Gardnerella biofilms. Histol Histopathol. 2014;29:567–576.
7.Srinivasan S, Hoffman NG, Morgan MT, et al. Bacterial communities in women with bacterial vaginosis. PLoS One. 2012;7:e37818.
8.Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA. 2011;108:4680–4687.
9.Ma B, Forney LJ, Ravel J. Vaginal microbiome: Rethinking health and disease. Annu Rev Microbiol. 2012;66:371–389.
10.Verstraelen H, Vilchez-Vargas R, Desimpel F, et al. Characterization of the human vaginal microbiome. BMC Microbiol. 2016;16:86.
11.Petrova MI, Reid G, Vaneechoutte M, Lebeer S. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol. 2017;8:897.
12.Amabebe E, Anumba DOC. The vaginal microenvironment: The physiologic role of Lactobacilli. Front Med. 2018;5:181.
13.Chee WJY, Chew SY, Than LTL. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microb Cell Fact. 2020;19:203.
14.Chieng WK, Abdul Jalal MI, Bedi JS, et al. Probiotics, a promising therapy to reduce the recurrence of bacterial vaginosis in women? A systematic review and meta-analysis of randomized controlled trials. Front Nutr. 2022;9:938838.
